J8502 Aprepitant - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Aprepitant

Brand Name:

Aponvie

Strength:

1mg

HCPCS:

J8502

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Antiemetic

Minor Drug Class:

Substance P/Neurokinin 1

Oral (Y/N):

No

FDA Approval Year:

2023

FDA Discontinuation Year:

CMS Effective Date:

March 18, 2026

CMS Discontinuation Date:

Status:

In Use